Related Content
March 30, 2015 โ AstraZeneca announced that the U.S. Food and Drug Administration (FDA) has approved a new ...
March 25, 2015 โ Adding the antiplatelet drug ticagrelor (Brilinta) to aspirin as long-term therapy after a heart attack ...
January 22, 2015 โ AstraZeneca announced that the PEGASUS-TIMI 54 study, a large-scale outcomes trial involving more ...
October 31, 2014 โ The American College of Cardiology announced 35 selected hospitals that are pioneering a team ...
August 20, 2014 โ AstraZeneca received confirmation from the United States Department of Justice that it is closing its ...
March 25, 2014 โ Patient enrollment has been completed four months ahead of plan in the Phase III clinical trial EUCLID ...
August 5, 2013 โ AstraZeneca announced results from a new sub-analysis of the PLATO study that evaluated the incidence ...
November 2, 2012 โ Patients who receive a drug-eluting stent (DES) and demonstrate low levels of platelet inhibition are ...
October 23, 2012 โ A study found that a tailored therapy approach that adjusts the loading dose of clopidogrel according ...
October 2, 2012 โ AstraZeneca has announced the results from a sub-analysis of PLATO that evaluated the effects of age ...